Logo image of AVTX.AS

AVANTIUM (AVTX.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:AVTX - NL0015002IE0 - Common Stock

6.1 EUR
-0.11 (-1.77%)
Last: 11/21/2025, 7:00:00 PM
Fundamental Rating

2

Overall AVTX gets a fundamental rating of 2 out of 10. We evaluated AVTX against 31 industry peers in the Professional Services industry. AVTX has a bad profitability rating. Also its financial health evaluation is rather negative. AVTX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AVTX had negative earnings in the past year.
AVTX had a negative operating cash flow in the past year.
In the past 5 years AVTX always reported negative net income.
AVTX had a negative operating cash flow in each of the past 5 years.
AVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFAVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

AVTX has a worse Return On Assets (-7.97%) than 87.88% of its industry peers.
With a Return On Equity value of -28.25%, AVTX is not doing good in the industry: 87.88% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.97%
ROE -28.25%
ROIC N/A
ROA(3y)-13.42%
ROA(5y)-20.86%
ROE(3y)-43.37%
ROE(5y)-45.66%
ROIC(3y)N/A
ROIC(5y)N/A
AVTX.AS Yearly ROA, ROE, ROICAVTX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

AVTX has a better Gross Margin (80.43%) than 72.73% of its industry peers.
In the last couple of years the Gross Margin of AVTX has remained more or less at the same level.
AVTX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-1.4%
AVTX.AS Yearly Profit, Operating, Gross MarginsAVTX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

More info and screens

0

2. Health

2.1 Basic Checks

AVTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AVTX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AVTX has been increased compared to 5 years ago.
AVTX has a worse debt/assets ratio than last year.
AVTX.AS Yearly Shares OutstandingAVTX.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AVTX.AS Yearly Total Debt VS Total AssetsAVTX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

AVTX has an Altman-Z score of -1.75. This is a bad value and indicates that AVTX is not financially healthy and even has some risk of bankruptcy.
AVTX has a Altman-Z score of -1.75. This is amonst the worse of the industry: AVTX underperforms 93.94% of its industry peers.
AVTX has a Debt/Equity ratio of 0.54. This is a neutral value indicating AVTX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.54, AVTX is in line with its industry, outperforming 51.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Altman-Z -1.75
ROIC/WACCN/A
WACC6.6%
AVTX.AS Yearly LT Debt VS Equity VS FCFAVTX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

2.3 Liquidity

AVTX has a Current Ratio of 0.19. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AVTX (0.19) is worse than 93.94% of its industry peers.
AVTX has a Quick Ratio of 0.19. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.18, AVTX is doing worse than 93.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.18
AVTX.AS Yearly Current Assets VS Current LiabilitesAVTX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

AVTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.49%, which is quite impressive.
Looking at the last year, AVTX shows a very negative growth in Revenue. The Revenue has decreased by -12.31% in the last year.
Measured over the past years, AVTX shows a quite strong growth in Revenue. The Revenue has been growing by 8.76% on average per year.
EPS 1Y (TTM)31.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.4%
Revenue 1Y (TTM)-12.31%
Revenue growth 3Y24.44%
Revenue growth 5Y8.76%
Sales Q2Q%-25.36%

3.2 Future

Based on estimates for the next years, AVTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.55% on average per year.
Based on estimates for the next years, AVTX will show a very strong growth in Revenue. The Revenue will grow by 54.51% on average per year.
EPS Next Y-9.56%
EPS Next 2Y21.89%
EPS Next 3Y20.73%
EPS Next 5Y9.55%
Revenue Next Year12.37%
Revenue Next 2Y47.56%
Revenue Next 3Y47.37%
Revenue Next 5Y54.51%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AVTX.AS Yearly Revenue VS EstimatesAVTX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AVTX.AS Yearly EPS VS EstimatesAVTX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AVTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVTX.AS Price Earnings VS Forward Price EarningsAVTX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVTX.AS Per share dataAVTX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as AVTX's earnings are expected to grow with 20.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.89%
EPS Next 3Y20.73%

More info and screens

0

5. Dividend

5.1 Amount

AVTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTIUM

AMS:AVTX (11/21/2025, 7:00:00 PM)

6.1

-0.11 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-13 2025-08-13
Earnings (Next)03-18 2026-03-18/amc
Inst Owners2.33%
Inst Owner ChangeN/A
Ins Owners2.07%
Ins Owner ChangeN/A
Market Cap153.72M
Revenue(TTM)18.76M
Net Income(TTM)-23.89M
Analysts80
Price Target20.7 (239.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.29%
PT rev (3m)-49.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)23.24%
EPS NY rev (3m)20.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-6.55%
Revenue NY rev (3m)-35.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.19
P/FCF N/A
P/OCF N/A
P/B 1.82
P/tB 1.89
EV/EBITDA N/A
EPS(TTM)-1.83
EYN/A
EPS(NY)-1.84
Fwd EYN/A
FCF(TTM)-2.59
FCFYN/A
OCF(TTM)-1.06
OCFYN/A
SpS0.74
BVpS3.36
TBVpS3.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.97%
ROE -28.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.43%
FCFM N/A
ROA(3y)-13.42%
ROA(5y)-20.86%
ROE(3y)-43.37%
ROE(5y)-45.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-1.4%
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 819.5%
Cap/Sales 205.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.18
Altman-Z -1.75
F-Score2
WACC6.6%
ROIC/WACCN/A
Cap/Depr(3y)919.16%
Cap/Depr(5y)570.66%
Cap/Sales(3y)308.29%
Cap/Sales(5y)199.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.4%
EPS Next Y-9.56%
EPS Next 2Y21.89%
EPS Next 3Y20.73%
EPS Next 5Y9.55%
Revenue 1Y (TTM)-12.31%
Revenue growth 3Y24.44%
Revenue growth 5Y8.76%
Sales Q2Q%-25.36%
Revenue Next Year12.37%
Revenue Next 2Y47.56%
Revenue Next 3Y47.37%
Revenue Next 5Y54.51%
EBIT growth 1Y-6.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.95%
EBIT Next 3Y24.15%
EBIT Next 5Y18.19%
FCF growth 1Y4.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-171.38%
OCF growth 3YN/A
OCF growth 5YN/A

AVANTIUM / AVTX.AS FAQ

Can you provide the ChartMill fundamental rating for AVANTIUM?

ChartMill assigns a fundamental rating of 2 / 10 to AVTX.AS.


Can you provide the valuation status for AVANTIUM?

ChartMill assigns a valuation rating of 1 / 10 to AVANTIUM (AVTX.AS). This can be considered as Overvalued.


How profitable is AVANTIUM (AVTX.AS) stock?

AVANTIUM (AVTX.AS) has a profitability rating of 1 / 10.


What is the earnings growth outlook for AVANTIUM?

The Earnings per Share (EPS) of AVANTIUM (AVTX.AS) is expected to decline by -9.56% in the next year.